Press Releases Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Market Closed - Nyse Other stock markets 04:00:02 2024-05-23 pm EDT			5-day change	1st Jan Change
87.46 ^USD	-3.05%		-2.94%	+14.70%

May. 22	Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	MT
May. 14	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences : First Quarter 2024 Fact Sheet	May. 15	PU
Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08	BU
Edwards Lifesciences: Q1 Earnings Snapshot	Apr. 25	AQ
Edwards Lifesciences Reports First Quarter Results	Apr. 25	BU
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024	Apr. 18	BU
Edwards Lifesciences - Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease without Knowing It	Apr. 08	AQ
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It	Apr. 07	BU
Precedential Federal Circuit Opinion Underscores Tension In Interpretation Of The Safe Harbor Of 35 U.S.C. § 271(e)(1)	Apr. 03	AQ
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	Mar. 11	BU
EDWARDS LIFESCIENCES TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTHCARE CONFERENCE	Feb. 26	AQ
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference	Feb. 23	BU
Edwards Lifesciences: Q4 Earnings Snapshot	Feb. 06	AQ
Edwards Lifesciences Reports Fourth Quarter Results	Feb. 06	BU
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve	Feb. 02	BU
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024	Jan. 30	BU
The Party Season Is Upon Us But What Does A Party Look Like To The Unified Patent Court?	Jan. 02	AQ
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 02	BU
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference	Dec. 07	BU
CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION	23-10-26	PR
TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION	23-10-26	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT